ITCI vs. TMO
Compare and contrast key facts about Intra-Cellular Therapies, Inc. (ITCI) and Thermo Fisher Scientific Inc. (TMO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ITCI or TMO.
Correlation
The correlation between ITCI and TMO is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ITCI vs. TMO - Performance Comparison
Key characteristics
ITCI:
1.39
TMO:
-0.12
ITCI:
3.27
TMO:
-0.03
ITCI:
1.40
TMO:
1.00
ITCI:
4.00
TMO:
-0.11
ITCI:
8.62
TMO:
-0.30
ITCI:
8.64%
TMO:
8.49%
ITCI:
53.73%
TMO:
20.89%
ITCI:
-87.64%
TMO:
-71.16%
ITCI:
0.00%
TMO:
-19.58%
Fundamentals
ITCI:
$13.67B
TMO:
$200.91B
ITCI:
-$0.87
TMO:
$16.51
ITCI:
0.00
TMO:
2.06
ITCI:
$481.41M
TMO:
$42.88B
ITCI:
$444.86M
TMO:
$17.79B
ITCI:
-$87.26M
TMO:
$10.46B
Returns By Period
In the year-to-date period, ITCI achieves a 53.98% return, which is significantly higher than TMO's 2.37% return. Over the past 10 years, ITCI has outperformed TMO with an annualized return of 18.17%, while TMO has yielded a comparatively lower 15.36% annualized return.
ITCI
53.98%
1.14%
72.66%
78.78%
39.20%
18.17%
TMO
2.37%
-7.32%
-12.02%
-4.73%
10.01%
15.36%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ITCI vs. TMO — Risk-Adjusted Performance Rank
ITCI
TMO
ITCI vs. TMO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Intra-Cellular Therapies, Inc. (ITCI) and Thermo Fisher Scientific Inc. (TMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ITCI vs. TMO - Dividend Comparison
ITCI has not paid dividends to shareholders, while TMO's dividend yield for the trailing twelve months is around 0.29%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ITCI Intra-Cellular Therapies, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TMO Thermo Fisher Scientific Inc. | 0.29% | 0.30% | 0.26% | 0.22% | 0.16% | 0.19% | 0.23% | 0.30% | 0.32% | 0.43% | 0.42% | 0.48% |
Drawdowns
ITCI vs. TMO - Drawdown Comparison
The maximum ITCI drawdown since its inception was -87.64%, which is greater than TMO's maximum drawdown of -71.16%. Use the drawdown chart below to compare losses from any high point for ITCI and TMO. For additional features, visit the drawdowns tool.
Volatility
ITCI vs. TMO - Volatility Comparison
The current volatility for Intra-Cellular Therapies, Inc. (ITCI) is 0.83%, while Thermo Fisher Scientific Inc. (TMO) has a volatility of 9.41%. This indicates that ITCI experiences smaller price fluctuations and is considered to be less risky than TMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ITCI vs. TMO - Financials Comparison
This section allows you to compare key financial metrics between Intra-Cellular Therapies, Inc. and Thermo Fisher Scientific Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities